Beyond expectations: disease duration and psychological burden in psoriatic arthritis
Loading...

Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Heidelberg
Open Access Color
Green Open Access
Yes
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
Abstract
This study aims to investigate the relationship between disease duration and psychological burden in PsA and to identify the risk factors associated with psychological distress. Patients with PsA who met CASPAR classification criteria enrolled by Turkish League Against Rheumatism (TLAR)-Network. Patients were categorized into three groups based on disease duration: early stage (< 5 years), middle stage (& GE; 5, < 10 years), and late stage (& GE; 10 years). All patients underwent clinical and laboratory assessment using standardized protocol and case report forms. The associations between psychological variables and clinical parameters were assessed by a multivariate analysis. Of the 1113 patients with PsA (63.9% female), 564 (%50.7) had high risk for depression and 263 (%23.6) for anxiety. The risk of psychological burden was similar across all PsA groups, and patients with a higher risk of depression and anxiety also experienced greater disease activity, poorer quality of life, and physical disability. Multivariate logistic regression revealed that female gender (OR = 1.52), PsAQoL (OR = 1.13), HAQ (OR = 1.99), FiRST score (OR = 1.14), unemployment/retired (OR = 1.48) and PASI head score (OR = 1.41) were factors that influenced the risk of depression, whereas the current or past enthesitis (OR = 1.45), PsAQoL (OR = 1.19), and FiRST score (OR = 1.26) were factors that influenced the risk of anxiety. PsA patients can experience a comparable level of psychological burden throughout the course of their disease. Several socio-demographic and disease-related factors may contribute to mental disorders in PsA. In the present era of personalized treatment for PsA, evaluating psychiatric distress can guide tailored interventions that improve overall well-being and reduce disease burden.
Description
Yurdakul, Ozan Volkan/0000-0003-4567-8133; Nas, Kemal/0000-0002-5845-0851; Acer Kasman, Sevtap/0000-0002-4805-0555; Orhan, Kevser/0000-0001-8639-751X; Ecesoy, Hilal/0000-0001-9274-168X; Kilic, Gamze/0000-0003-1998-0988; Mülkoglu, Cevriye/0000-0001-9113-3885; KILIÇ, Erkan/0000-0003-4355-4356; şen, nesrin/0000-0003-0966-0075; Keskin, Yasar/0000-0003-4457-5917; KAMANLI, AYHAN/0000-0001-5299-7250; TEKEOGLU, IBRAHIM/0000-0003-3395-7178; cuzdan balta, nihan/0000-0001-7238-657X; alkan, hakan/0000-0001-8461-9131
Keywords
Anxiety, Arthritis, Psoriatic, Depression, Rheumatic diseases, Quality of life, Male, Psoriatic Arthritis Quality of Life, cost of illness, clinical outcome, Psoriatic, Anxiety, high risk patient, Severity of Illness Index, mental disease, disease burden, Rheumatic diseases, Psoriasis Area and Severity Index, Cost of Illness, Surveys and Questionnaires, disease modifying antirheumatic drug, gender, Health Assessment Questionnaire, anxiety disorder, comparative study, psoriatic arthritis, musculoskeletal disease assessment, conventional synthetic disease modifying antirheumatic drug, Depression, adult, disease course, Fibromyalgia Rapid Screening Tool, unclassified drug, female, Anxiety; Arthritis; Psoriatic; Depression; Rheumatic diseases; Quality of life, retirement, risk factor, biological disease modifying antirheumatic drug, biological therapy, laboratory test, depression, Female, biological product, Quality of life, unemployment, quality of life assessment, distress syndrome, 610, psychology, patient-reported outcome, Article, male, motivation, Rheumatic Diseases, physical disability, cross-sectional study, severity of illness index, Humans, human, sociodemographics, Motivation, Arthritis, enthesitis, questionnaire, disease association, Arthritis, Psoriatic, clinical assessment, staging, major clinical study, quality of life, Classification Criteria for Psoriatic Arthritis, Quality of Life, observational study, disease duration, disease activity
Fields of Science
Citation
WoS Q
Q2
Scopus Q
Q2

OpenCitations Citation Count
7
Source
Rheumatology International
Volume
43
Issue
Start Page
1695
End Page
1704
PlumX Metrics
Citations
Scopus : 8
PubMed : 6
Captures
Mendeley Readers : 18
SCOPUS™ Citations
8
checked on Mar 06, 2026
Web of Science™ Citations
10
checked on Mar 06, 2026
Page Views
12
checked on Mar 06, 2026
Google Scholar™


